Anatomic & Clinical Pathology in Fort Lauderdale, FL
13 verified anatomic & clinical pathology doctors in Fort Lauderdale.
Pathologists diagnose disease by examining tissue, blood, and other lab specimens.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. David Zhang, MD
Anatomic & Clinical Pathology
CMS Open Payments· $864.60 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$864.60
Total received
31
Transactions
2
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to David Zhang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ramila Gavan, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Shirley Amin, MD
Anatomic & Clinical Pathology
CMS Open Payments· $731.93 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$731.93
Total received
7
Transactions
6
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Shirley Amin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hong Wang, MD
Anatomic & Clinical Pathology
CMS Open Payments· $41.25 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$41.25
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Hong Wang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Peter Johnson, MD
Anatomic & Clinical Pathology
CMS Open Payments· $828.73 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$828.73
Total received
8
Transactions
7
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Peter Johnson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lewis Starasoler, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Aftab Khan, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Charles Abbott, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Farhad Askarian, MD
Anatomic & Clinical Pathology
CMS Open Payments· $87.46 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$87.46
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Farhad Askarian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Viviana Lorda Seijo, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Harold Garber, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Avi Kandel, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Abigail Alexander, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.